Arcadia Biosciences, Inc. short interest in 2019
In 2019, Arcadia Biosciences, Inc.'s disclosed short interest ran from 6.29% of shares outstanding on 15 Jan 2019 to 9.20% on 31 Dec 2019, a change of +2.91 percentage points. The year's high was 27.09% on 15 Aug 2019 and its low 1.59% on 15 Jul 2019, averaging 7.99% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.37 days on 15 Jan 2019. Full history: Arcadia Biosciences, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 6.29% (15 Jan 2019)
- End of year
- 9.20% (31 Dec 2019)
- Change
- +2.91 pp
- High
- 27.09% (15 Aug 2019)
- Low
- 1.59% (15 Jul 2019)
- Average
- 7.99%
- Highest days to cover
- 7.37 (15 Jan 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 6.29% | 7.37 | |
| 31 Jan 2019 | 5.92% | 3.87 | |
| 15 Feb 2019 | 7.03% | 1.19 | |
| 28 Feb 2019 | 6.67% | 1.00 | |
| 15 Mar 2019 | 11.68% | 1.00 | |
| 29 Mar 2019 | 9.78% | 2.23 | results (8-K) |
| 15 Apr 2019 | 5.34% | 1.30 | 10-K filed |
| 30 Apr 2019 | 3.53% | 2.15 | |
| 15 May 2019 | 3.50% | 1.84 | 10-Q filed, results (8-K) |
| 31 May 2019 | 2.93% | 3.92 | |
| 14 Jun 2019 | 3.10% | 1.00 | |
| 15 Jul 2019 | 1.59% | 1.00 | |
| 31 Jul 2019 | 1.88% | 1.00 | |
| 15 Aug 2019 | 27.09% | 1.00 | 10-Q filed, results (8-K) |
| 31 Oct 2019 | 11.15% | 1.62 | |
| 15 Nov 2019 | 13.60% | 1.19 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 10.98% | 2.82 | |
| 13 Dec 2019 | 10.55% | 3.04 | |
| 31 Dec 2019 | 9.20% | 3.39 |
See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.